Clinical impact of transesophageal echocardiography in patients with stroke without clinical evidence of cardiovascular sources of emboli

Solange Bernardes Tatani, Márcia Maiumi Fukujima, Joao Lima, Luiz Darcy Cortez Ferreira, Claudia G. Monaco Ghefter, Gilmar Fernandas Prado, Zara Babayan, Lyamara Apostólico De Azevedo

Research output: Contribution to journalArticle

Abstract

Objective - The purpose of this study is to evaluate the impact of transeophageal echocardiography on management of patients at low-risk for cardiogenic embolism to prevent new potential cardiovascular sources of emboli. Methods - We studied 69 patients with ischemia stroke at low-risk for cardiogenic embolism. Transeophageal echocardiography was performed to access: left atrium enlargement; communication or aneurysm of the interatrial septum; patent foramen ovale; spontaneous echo contrast or intracavitary thrombi; the presence of intraaortic atherosclerotic plaques or thrombi; significant valvar morphologic alteration or dysfunction; left ventricle enlargement, hypertrophy, or contractile abnormality. Transesophageal echocardiography altered clinical management, and we adopted anticoagulant therapy or another procedure apart from the use ofacetylsalicylic acid. Results - Transeophageal echocardiography detected at least one abnormality in 40 cases (58%). Clinical conduct was adjusted after the performance of transesophageal echocardiography in 11 patients (15.9%); anticoagulation was added in 10 cases and surgical correction in one patient. Conclusion - Transeophageal echocardiography was a very useful tool in the secondary prevention for stroke in patients at low risk for cardiogenic embolism.

Original languageEnglish (US)
Pages (from-to)458-461
Number of pages4
JournalArquivos Brasileiros de Cardiologia
Volume76
Issue number6
StatePublished - 2001

Fingerprint

Transesophageal Echocardiography
Embolism
Stroke
Echocardiography
Thrombosis
Patent Foramen Ovale
Atherosclerotic Plaques
Secondary Prevention
Heart Atria
Anticoagulants
Hypertrophy
Heart Ventricles
Aneurysm
Ischemia
Communication
Acids

Keywords

  • Embolism
  • Stroke
  • Transeophageal echocardiography

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Tatani, S. B., Fukujima, M. M., Lima, J., Ferreira, L. D. C., Monaco Ghefter, C. G., Prado, G. F., ... De Azevedo, L. A. (2001). Clinical impact of transesophageal echocardiography in patients with stroke without clinical evidence of cardiovascular sources of emboli. Arquivos Brasileiros de Cardiologia, 76(6), 458-461.

Clinical impact of transesophageal echocardiography in patients with stroke without clinical evidence of cardiovascular sources of emboli. / Tatani, Solange Bernardes; Fukujima, Márcia Maiumi; Lima, Joao; Ferreira, Luiz Darcy Cortez; Monaco Ghefter, Claudia G.; Prado, Gilmar Fernandas; Babayan, Zara; De Azevedo, Lyamara Apostólico.

In: Arquivos Brasileiros de Cardiologia, Vol. 76, No. 6, 2001, p. 458-461.

Research output: Contribution to journalArticle

Tatani, SB, Fukujima, MM, Lima, J, Ferreira, LDC, Monaco Ghefter, CG, Prado, GF, Babayan, Z & De Azevedo, LA 2001, 'Clinical impact of transesophageal echocardiography in patients with stroke without clinical evidence of cardiovascular sources of emboli', Arquivos Brasileiros de Cardiologia, vol. 76, no. 6, pp. 458-461.
Tatani, Solange Bernardes ; Fukujima, Márcia Maiumi ; Lima, Joao ; Ferreira, Luiz Darcy Cortez ; Monaco Ghefter, Claudia G. ; Prado, Gilmar Fernandas ; Babayan, Zara ; De Azevedo, Lyamara Apostólico. / Clinical impact of transesophageal echocardiography in patients with stroke without clinical evidence of cardiovascular sources of emboli. In: Arquivos Brasileiros de Cardiologia. 2001 ; Vol. 76, No. 6. pp. 458-461.
@article{75473a0d9965474db9f52ca365be61bc,
title = "Clinical impact of transesophageal echocardiography in patients with stroke without clinical evidence of cardiovascular sources of emboli",
abstract = "Objective - The purpose of this study is to evaluate the impact of transeophageal echocardiography on management of patients at low-risk for cardiogenic embolism to prevent new potential cardiovascular sources of emboli. Methods - We studied 69 patients with ischemia stroke at low-risk for cardiogenic embolism. Transeophageal echocardiography was performed to access: left atrium enlargement; communication or aneurysm of the interatrial septum; patent foramen ovale; spontaneous echo contrast or intracavitary thrombi; the presence of intraaortic atherosclerotic plaques or thrombi; significant valvar morphologic alteration or dysfunction; left ventricle enlargement, hypertrophy, or contractile abnormality. Transesophageal echocardiography altered clinical management, and we adopted anticoagulant therapy or another procedure apart from the use ofacetylsalicylic acid. Results - Transeophageal echocardiography detected at least one abnormality in 40 cases (58{\%}). Clinical conduct was adjusted after the performance of transesophageal echocardiography in 11 patients (15.9{\%}); anticoagulation was added in 10 cases and surgical correction in one patient. Conclusion - Transeophageal echocardiography was a very useful tool in the secondary prevention for stroke in patients at low risk for cardiogenic embolism.",
keywords = "Embolism, Stroke, Transeophageal echocardiography",
author = "Tatani, {Solange Bernardes} and Fukujima, {M{\'a}rcia Maiumi} and Joao Lima and Ferreira, {Luiz Darcy Cortez} and {Monaco Ghefter}, {Claudia G.} and Prado, {Gilmar Fernandas} and Zara Babayan and {De Azevedo}, {Lyamara Apost{\'o}lico}",
year = "2001",
language = "English (US)",
volume = "76",
pages = "458--461",
journal = "Arquivos Brasileiros de Cardiologia",
issn = "0066-782X",
publisher = "Arquivos Brasileiros de Cardiologia",
number = "6",

}

TY - JOUR

T1 - Clinical impact of transesophageal echocardiography in patients with stroke without clinical evidence of cardiovascular sources of emboli

AU - Tatani, Solange Bernardes

AU - Fukujima, Márcia Maiumi

AU - Lima, Joao

AU - Ferreira, Luiz Darcy Cortez

AU - Monaco Ghefter, Claudia G.

AU - Prado, Gilmar Fernandas

AU - Babayan, Zara

AU - De Azevedo, Lyamara Apostólico

PY - 2001

Y1 - 2001

N2 - Objective - The purpose of this study is to evaluate the impact of transeophageal echocardiography on management of patients at low-risk for cardiogenic embolism to prevent new potential cardiovascular sources of emboli. Methods - We studied 69 patients with ischemia stroke at low-risk for cardiogenic embolism. Transeophageal echocardiography was performed to access: left atrium enlargement; communication or aneurysm of the interatrial septum; patent foramen ovale; spontaneous echo contrast or intracavitary thrombi; the presence of intraaortic atherosclerotic plaques or thrombi; significant valvar morphologic alteration or dysfunction; left ventricle enlargement, hypertrophy, or contractile abnormality. Transesophageal echocardiography altered clinical management, and we adopted anticoagulant therapy or another procedure apart from the use ofacetylsalicylic acid. Results - Transeophageal echocardiography detected at least one abnormality in 40 cases (58%). Clinical conduct was adjusted after the performance of transesophageal echocardiography in 11 patients (15.9%); anticoagulation was added in 10 cases and surgical correction in one patient. Conclusion - Transeophageal echocardiography was a very useful tool in the secondary prevention for stroke in patients at low risk for cardiogenic embolism.

AB - Objective - The purpose of this study is to evaluate the impact of transeophageal echocardiography on management of patients at low-risk for cardiogenic embolism to prevent new potential cardiovascular sources of emboli. Methods - We studied 69 patients with ischemia stroke at low-risk for cardiogenic embolism. Transeophageal echocardiography was performed to access: left atrium enlargement; communication or aneurysm of the interatrial septum; patent foramen ovale; spontaneous echo contrast or intracavitary thrombi; the presence of intraaortic atherosclerotic plaques or thrombi; significant valvar morphologic alteration or dysfunction; left ventricle enlargement, hypertrophy, or contractile abnormality. Transesophageal echocardiography altered clinical management, and we adopted anticoagulant therapy or another procedure apart from the use ofacetylsalicylic acid. Results - Transeophageal echocardiography detected at least one abnormality in 40 cases (58%). Clinical conduct was adjusted after the performance of transesophageal echocardiography in 11 patients (15.9%); anticoagulation was added in 10 cases and surgical correction in one patient. Conclusion - Transeophageal echocardiography was a very useful tool in the secondary prevention for stroke in patients at low risk for cardiogenic embolism.

KW - Embolism

KW - Stroke

KW - Transeophageal echocardiography

UR - http://www.scopus.com/inward/record.url?scp=0035379235&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035379235&partnerID=8YFLogxK

M3 - Article

C2 - 11449291

AN - SCOPUS:0035379235

VL - 76

SP - 458

EP - 461

JO - Arquivos Brasileiros de Cardiologia

JF - Arquivos Brasileiros de Cardiologia

SN - 0066-782X

IS - 6

ER -